← All trials
NCT04538313
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 26, 2020
- Primary completion
- Oct 31, 2022
- Completion date
- Oct 31, 2022
- First posted
- Sep 4, 2020
- Last posted
- Sep 4, 2020
- Enrollment
- 40
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- CAR-T (Shanghai) Biotechnology Co.,Ltd.Lead sponsor
- Eastern Hepatobiliary Surgery HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.